The myocardial and coronary histopathology and pathogenesis of hypoplastic left heart syndrome

Charles R Cole1, Pirooz Eghtesady2

  • 11University of Cincinnati,Cincinnati,Ohio,United States of America.

Insights

Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect with a high mortality rate. Further research into its pathology and associated conditions is needed to understand its causes and find a cure.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Genetics

Background:

  • Hypoplastic left heart syndrome (HLHS) is a critical congenital heart defect (CHD) with a near-uniform fatal outcome without intervention.
  • The etiology of HLHS remains largely unknown, hindering the development of effective treatments or cures.
  • The condition presents significant genetic and anatomical heterogeneity, necessitating a re-evaluation of existing hypotheses.

Purpose of the Study:

  • To explore the pathogenesis of HLHS by examining its distinct myocardial and coronary pathology.
  • To investigate the association between HLHS and endocardial fibroelastosis (EFE).
  • To provide a comprehensive review to guide future research directions.

Main Methods:

  • Literature review focusing on HLHS.
  • Analysis of histological and vascular variations in HLHS.
  • Evaluation of the relationship between HLHS and EFE.

Main Results:

  • HLHS exhibits unique myocardial and coronary pathologies.
  • A significant association exists between HLHS and the endocardial fibroelastosis reaction.
  • Genetic and anatomical heterogeneity are key features of HLHS.

Conclusions:

  • Understanding the specific pathologies of HLHS is crucial for elucidating its pathogenesis.
  • The association with EFE warrants further investigation.
  • Further research into the histological and vascular variations of HLHS is essential for advancing treatment strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
748
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
834
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
603
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K